BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang S, Xie B, Wang L, Yang H, Zhang H, Chen Y, Wang F, Liu C, He H. Macrophage-mediated vascular permeability via VLA4/VCAM1 pathway dictates ascites development in ovarian cancer. J Clin Invest 2021;131:140315. [PMID: 33295887 DOI: 10.1172/JCI140315] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Fanale D, Dimino A, Pedone E, Brando C, Corsini LR, Filorizzo C, Fiorino A, Lisanti MC, Magrin L, Randazzo U, Bazan Russo TD, Russo A, Bazan V. Prognostic and Predictive Role of Tumor-Infiltrating Lymphocytes (TILs) in Ovarian Cancer. Cancers 2022;14:4344. [DOI: 10.3390/cancers14184344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Yang Y, Zhao T, Chen Q, Li Y, Xiao Z, Xiang Y, Wang B, Qiu Y, Tu S, Jiang Y, Nan Y, Huang Q, Ai K. Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC. Advanced Science. [DOI: 10.1002/advs.202202797] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Peña-romero AC, Orenes-piñero E. Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers. Cancers 2022;14:1681. [DOI: 10.3390/cancers14071681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Huang J, Wang G, Liao K, Xie N, Deng K. UCP1 modulates immune infiltration level and survival outcome in ovarian cancer patients. J Ovarian Res 2022;15. [DOI: 10.1186/s13048-022-00951-z] [Reference Citation Analysis]
5 Ji H, Ren M, Liu T, Sun Y. Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment. Dis Markers 2021;2021:5350232. [PMID: 34840630 DOI: 10.1155/2021/5350232] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Xu T, Yu S, Zhang J, Wu S. Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers. J Hematol Oncol 2021;14:181. [PMID: 34717710 DOI: 10.1186/s13045-021-01198-9] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
7 Cheng L, Zhang D, Yan W. Ultrasound‑targeted microbubble destruction‑mediated overexpression of Sirtuin 3 inhibits the progression of ovarian cancer. Oncol Rep 2021;46:220. [PMID: 34396428 DOI: 10.3892/or.2021.8171] [Cited by in F6Publishing: 2] [Reference Citation Analysis]